(Q37849351)

24 August 2017

title

Treatment of chlamydial infections (English)

1 reference

24 August 2017

author name string

Margaret R Hammerschlag

series ordinal

1

1 reference

24 August 2017

Stephan A Kohlhoff

series ordinal

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

9 February 2012

1 reference

Expert Opinion on Pharmacotherapy

24 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

24 August 2017

volume

13

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

545-552

1 reference

Genome sequencing and our understanding of chlamydiae

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Host cell responses to Chlamydia pneumoniae in gamma interferon-induced persistence overlap those of productive infection and are linked to genes involved in apoptosis, cell cycle, and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Chlamydial development is adversely affected by minor changes in amino acid supply, blood plasma amino acid levels, and glucose deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Chlamydial persistence: beyond the biphasic paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Chlamydia trachomatis persistence: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Differential expression of chlamydial signal transduction genes in normal and interferon gamma-induced persistent Chlamydophila pneumoniae infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Differential expression of genes encoding membrane proteins between acute and continuous Chlamydia pneumoniae infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Therapeutic approaches to Chlamydia infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Antibiotic resistance in Chlamydiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Serial passage of Chlamydia spp. in sub-inhibitory fluoroquinolone concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Emergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Serine-to-asparagine substitution in the GyrA gene leads to quinolone resistance in moxifloxacin-exposed Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Effect of gemifloxacin on viability of Chlamydia pneumoniae (Chlamydophila pneumoniae) in an in vitro continuous infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Repeated Chlamydia trachomatis genital infections in adolescent women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Susceptibilities of Chlamydia trachomatis isolates causing uncomplicated female genital tract infections and pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Lack of macrolide resistance in Chlamydia trachomatis after mass azithromycin distributions for trachoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Delayed microbial cure of lymphogranuloma venereum proctitis with doxycycline treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Doxycycline failure in lymphogranuloma venereum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Unusual presentation of early lymphogranuloma venereum in an HIV-1 infected patient: effective treatment with 1 g azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Epidemiology and Aetiology of Community-acquired Pneumonia (CAP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Etiology and treatment of community-acquired pneumonia in ambulatory children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

A trial of clarithromycin for the treatment of suboptimally controlled asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

The effect of telithromycin in acute exacerbations of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.658776

10.1517/14656566.2012.658776

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference